NB Paramed
The computed 12-month bankruptcy probability of NB Paramed is 1.1% (low). The 2025 annual accounts show equity of €97k and a net result of €53k. Equity is growing by ~2.9% per year across the filed fiscal years. The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €97k |
| Net result | €53k |
| Active | 11 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2025 |
|---|---|
| Revenue | €124k |
| EBITDA | €78k |
| Net profit | €53k |
| Cash flow | €58k |
| Staff costs | - |
| Income taxes | €20k |
| Dividends | - |
| Total assets | €233k |
| Equity | €97k |
| Debt | €136k |
| of which ≤ 1y | €136k |
| of which > 1y | - |
| Working capital | €85k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 1.63 |
| Quick ratio | 1.63 |
| Working capital ratio | 36.5% |
| Solvency | 41.7% |
| Debt / equity | 1.40 |
| Long-term debt ratio | - |
| Interest coverage | 1439.73 |
| Gross margin | 64.2% |
| Net margin | 42.5% |
| ROA | 22.6% |
| ROE | 54.2% |
| EBITDA margin | 62.7% |
| Days sales outstanding | 0d |
| Days payable outstanding | 6d |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €233k |
| Fixed assets | 21/28 | €12k |
| Tangible fixed assets | 22/27 | €12k |
| Current assets | 29/58 | €221k |
| Amounts receivable within one year | 40/41 | €100 |
| Cash & bank | 54/58 | €220k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €233k |
| Equity | 10/15 | €97k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €79k |
| Amounts payable | 17/49 | €136k |
| Amounts payable within one year | 42/48 | €136k |
| Trade debts payable within one year | 44 | €672 |
| Income statement | ||
| Turnover | 70 | €124k |
| Gross operating margin | 9900 | €80k |
| Operating result | 9901 | €72k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €54 |
| Result before taxes | 9903 | €72k |
| Income taxes | 67/77 | €20k |
| Net result for the period | 9904 | €53k |
| Result to be appropriated | 9905 | €53k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 06-05-2015 |
| Status | Active |
| Postal code | 5350 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92040D0343/00G006 | Wallonia | 987 m² | 1 · 141 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-11-2023 Nicolas BALTHAZART appointed as director
- Nicolas BALTHAZART, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Nicolas BALTHAZART",
"address": null,
"birth_date": null,
"profession": "g\u00E9rant",
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": null,
"statutory": "ambtshalve",
"compensated": null,
"effective_date": null,
"evidence_quote": "7/ Il a \u00E9t\u00E9 constat\u00E9 que Monsieur Nicolas BALTHAZART, g\u00E9rant de la soci\u00E9t\u00E9 au moment de l\u2019entr\u00E9e en vigueur du Code des soci\u00E9t\u00E9s et des associations, est automatiquement devenu administrateur de la soci\u00E9t\u00E9.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "St\u00E9phane WATILLON",
"firm_city": null,
"firm_name": null,
"office_city": "Namur",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-11-23",
"filing_date": "2023-11-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-11-17",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0629.825.255",
"name_full": "NB Paramed",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "St\u00E9phane WATILLON",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition conforme du proc\u00E8s-verbal modificatif",
"texte des statuts coordonn\u00E9s"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | NB Paramed |